The Melanocortin Receptor System

There are five melanocortin receptor subtypes (MC1R–MC5R), each with distinct tissue distribution and functional roles. MC1R is expressed primarily in melanocytes and governs pigmentation. MC2R is the ACTH receptor in the adrenal gland. MC3R and MC4R are expressed in the CNS and regulate energy homeostasis, sexual function, and inflammation. MC5R is found in exocrine glands. Natural melanocortin peptides (α-MSH, β-MSH) activate these receptors with varying selectivity; Melanotan II (MT-2) activates all five.

MT-2 Structure & Receptor Profile

Melanotan II is a cyclic 7-amino acid analog of α-MSH, designed to be more potent and metabolically stable than the native hormone. Its cyclic structure (via a disulfide-like lactam bridge) dramatically increases receptor binding affinity across all five MC receptor subtypes. This broad activation profile is what makes MT-2 useful for research studying multiple melanocortin pathways simultaneously — and also what creates its range of side effects in animal models.

Pigmentation Pathway: MC1R

MC1R activation in melanocytes triggers the switch from pheomelanin (yellow/red pigment) to eumelanin (brown/black pigment) production. This is the mechanism behind MT-2's pigmentation effects in research. MC1R activation also has independent immunomodulatory effects in skin — it promotes anti-inflammatory signaling, which has been studied in UV damage and melanoma research contexts.

CNS Pathways: MC4R and Sexual Function Research

MC4R is expressed in the paraventricular nucleus of the hypothalamus and plays a key role in sexual arousal, erection, and ejaculation physiology. MT-2 research in this area led to the development of PT-141 (bremelanotide), a cyclic analog with higher MC4R selectivity. MT-2 is non-selective — it activates MC4R alongside MC1R and MC3R, making it less useful for isolating CNS pathway research compared to PT-141.

Documentation Standards

MT-2 is a 7-amino acid cyclic peptide with MW ~1,024.2 Da. HPLC purity should be ≥98%, with the cyclic disulfide structure confirmed by MS. The cyclic structure is critical — linearized MT-2 (from disulfide reduction or incorrect synthesis) has significantly different receptor binding characteristics. Mass spectrometry should show the correct molecular ion, confirming ring integrity.